课题基金 / 基金详情

项目摘要

项目成果

Carol Ann Deaton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A common feature of Alzheimer’s disease (AD), as well as other older age onset neurodegenerative diseases, is the accumulation of misfolded, abnormally modified proteins. In AD, aggregates of tau are a classical hallmark. A significant contributing factor to the formation of these proteinaceous accumulations is dysfunction of the lysosome-dependent degradative pathways. Interestingly, the majority of autosomal dominant familial AD (FAD) cases are caused by mutations in presenilin 1 (PS1), the catalytic subunit of the  secretase complex, which also likely facilitates lysosomal function. However, the role of PS1 in mediating lysosome biology and the clearance of tau has not been fully delineated. Given previous studies and our preliminary data, the UNDERLYING PREMISE of this proposal is that in neurons PS1 plays a fundamental role in regulating the function of lysosomes and, thus, tau turnover. Lysosomes play a key role in maintaining proteostasis as multiple degradative pathways direct their cargos to the lysosome for degradation/recycling. Alterations in the activity or intracellular localization of lysosomes contribute to the pathogenic processes of these neurodegenerative diseases. Given the importance of lysosome function to neuron health, understanding how PS1 impacts lysosome biology is of high importance. CRITICAL KNOWLEDGE GAPS include: how depletion of PS1 in primary neurons impacts lysosome pH, the effects of PS1 depletion on autophagosome-lysosome and endosome-lysosome fusion, the impact of PS1 depletion on tau turnover and how re-acidification of lysosomes in neurons with PS1 depleted affects the PS1-induced lysosomal fusion defects and deficiencies in tau turnover. Considering these critical knowledge gaps the OVERALL HYPOTHESIS is that depletion of PS1 leads to impairment of lysosome function, localization and fusion events, which negatively impact tau clearance. In the context of this overall hypothesis, the specific aims of this proposal are to test the hypotheses: (1) that PS1 plays a role in the acidification, activity, and localization of lysosomes and other degradative vesicles within different neuronal compartments and (2) that vesicle- mediated processing/clearance and intraneuronal localization of tau is impaired by knockdown of PS1. These studies will be carried out using primary rat cortical neuron cultures. Overall this a transformative project that addresses significant gaps in our scientific knowledge. The proposal is innovative in conceptualizing PS1 as a key regulator of lysosome function and thus a significant contributor to proteostasis in general and tau more specifically. Further, technically it is innovative as we will be using an optogenetically driven proton pump to decrease the pH of lysosomes after PS1 knockdown to determine if maintaining an acidified lysosome is sufficient to restore its function. The IMPACT of these studies will be a significant contribution to our understanding of the role of PS1 in regulating tau biology via lysosomal function, thus informing general perspectives of neurobiological degeneration in aging. .
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3233/jad-200598
发表时间: 2020
期刊: Journal of Alzheimer's disease : JAD
影响因子: --
作者: [Deaton CA, Johnson GVW]
通讯作者: Johnson GVW
Presenilin 1 Modulates Lysosome Function and Tau Degradation
  • 批准号:
    10368913
  • 项目类别:
  • 资助金额:
    $5.1万
  • 财政年份:
    2020
  • 负责人:
    Carol Ann Deaton
  • 依托单位:
Presenilin 1 Modulates Lysosome Function and Tau Degradation
  • 批准号:
    10407658
  • 项目类别:
  • 资助金额:
    $5.18万
  • 财政年份:
    2020
  • 负责人:
    Carol Ann Deaton
  • 依托单位:
海外基金